Literature DB >> 11413786

Primary and secondary prevention of heart disease: can we curb the global epidemic?

S C Smith1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11413786      PMCID： PMC2194419     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  16 in total

Review 1.  Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement.

Authors:  L Mosca; S M Grundy; D Judelson; K King; M Limacher; S Oparil; R Pasternak; T A Pearson; R F Redberg; S C Smith; M Winston; S Zinberg
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

2.  Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action.

Authors:  T A Pearson; S C Smith; P Poole-Wilson
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

3.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

Authors:  S Sans; H Kesteloot; D Kromhout
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

Review 4.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

5.  Preventing heart attack and death in patients with coronary disease.

Authors:  S C Smith; S N Blair; M H Criqui; G F Fletcher; V Fuster; B J Gersh; A M Gotto; K L Gould; P Greenland; S M Grundy
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

Review 6.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

7.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Authors:  T A Pearson; I Laurora; H Chu; S Kafonek
Journal:  Arch Intern Med       Date:  2000-02-28

8.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.

Authors:  G T O'Connor; H B Quinton; N D Traven; L D Ramunno; T A Dodds; T A Marciniak; J E Wennberg
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

9.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project.

Authors:  E F Ellerbeck; S F Jencks; M J Radford; T F Kresowik; A S Craig; J A Gold; H M Krumholz; R A Vogel
Journal:  JAMA       Date:  1995-05-17       Impact factor: 56.272

10.  Compensatory enlargement of human atherosclerotic coronary arteries.

Authors:  S Glagov; E Weisenberg; C K Zarins; R Stankunavicius; G J Kolettis
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245
View more
  1 in total

1.  Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.

Authors:  Oleg Pisarenko; Valentin Shulzhenko; Irina Studneva; Yulia Pelogeykina; Alexander Timoshin; Rodica Anesia; Philippe Valet; Angelo Parini; Oksana Kunduzova
Journal:  Br J Pharmacol       Date:  2015-04-23       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.